Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cutler

Showing results (541-550 of 915) with videos related to

Pageof 92
Sort By:
Natural Product Communications|November 27, 2018
Quantitative Determination of Betaine, Choline, Acetylcholine, and 20-Hydroxyecdysone Simultaneously from Atriplex Species by UHPLC-UV-MSYan-Hong Wang, Mallika Kumarihamy, Mei Wang, et al.
Plos One|March 25, 2009
Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunitySonja Grosskinsky, Melanie Schott, Christiane Brenner, et al.
Journal of Natural Products|June 3, 2015
Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid ReceptorsAmer Tarawneh, Francisco León, Sara Pettaway, et al.
CNS Spectrums|October 17, 2015
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II resultsRachelle S Doody, Stephen D'Amico, Andrew J Cutler, et al.
Journal of Chemical Information and Modeling|January 10, 2017
Molecular Modeling Evaluation of the Enantiomers of a Novel Adenylyl Cyclase 2 InhibitorNeha Rana, Jason M Conley, Monica Soto-Velasquez, et al.
Journal of Child and Adolescent Psychopharmacology|May 13, 2014
Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderAnn C Childress, Andrew J Cutler, Keith Saylor, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 23, 2011
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderRobert L Findling, Ann C Childress, Andrew J Cutler, et al.
Chemistry & Biodiversity|December 14, 2011
Antifungal metabolites from the roots of Diospyros virginiana by overpressure layer chromatographyXiaoning Wang, Eman Habib, Francisco León, et al.
CNS Drugs|March 26, 2026
Correction: An Open‑Label Extension Study Assessing the Long‑Term Safety and Efficacy of Viloxazine Extended‑Release Capsules in Adults with Attention‑Deficit/Hyperactivity DisorderAnn Childress, Andrew J Cutler, Lenard A Adler, et al.
CNS Drugs|October 7, 2024
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity DisorderAnn Childress, Andrew J Cutler, Lenard A Adler, et al.
Pageof 92

Showing results (541-550 of 915) with videos related to

Sort By:
Pageof 92
Natural Product Communications|November 27, 2018
Quantitative Determination of Betaine, Choline, Acetylcholine, and 20-Hydroxyecdysone Simultaneously from Atriplex Species by UHPLC-UV-MSYan-Hong Wang, Mallika Kumarihamy, Mei Wang, et al.
Plos One|March 25, 2009
Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunitySonja Grosskinsky, Melanie Schott, Christiane Brenner, et al.
Journal of Natural Products|June 3, 2015
Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid ReceptorsAmer Tarawneh, Francisco León, Sara Pettaway, et al.
CNS Spectrums|October 17, 2015
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II resultsRachelle S Doody, Stephen D'Amico, Andrew J Cutler, et al.
Journal of Chemical Information and Modeling|January 10, 2017
Molecular Modeling Evaluation of the Enantiomers of a Novel Adenylyl Cyclase 2 InhibitorNeha Rana, Jason M Conley, Monica Soto-Velasquez, et al.
Journal of Child and Adolescent Psychopharmacology|May 13, 2014
Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderAnn C Childress, Andrew J Cutler, Keith Saylor, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 23, 2011
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderRobert L Findling, Ann C Childress, Andrew J Cutler, et al.
Chemistry & Biodiversity|December 14, 2011
Antifungal metabolites from the roots of Diospyros virginiana by overpressure layer chromatographyXiaoning Wang, Eman Habib, Francisco León, et al.
CNS Drugs|March 26, 2026
Correction: An Open‑Label Extension Study Assessing the Long‑Term Safety and Efficacy of Viloxazine Extended‑Release Capsules in Adults with Attention‑Deficit/Hyperactivity DisorderAnn Childress, Andrew J Cutler, Lenard A Adler, et al.
CNS Drugs|October 7, 2024
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity DisorderAnn Childress, Andrew J Cutler, Lenard A Adler, et al.
Pageof 92